Adani Enterp.

2581.3 22.60

Adani Ports

1433 1.30

Apollo Hospitals

7220 30.50

Asian Paints

2401.6 -37.60

Axis Bank

1172.7 -1.10

Bajaj Auto

8087.5 20.50

Bajaj Finance

918.85 -14.65

Bajaj Finserv

2003.6 -13.60

Bharat Electron

407.3 -2.00

Bharti Airtel

1920.9 -1.00

Cipla

1484 -1.00

Coal India

383.85 2.90

Dr Reddy's Labs

1250.6 -4.10

Eicher Motors

5540.5 -72.00

Eternal Ltd

270.6 7.25

Grasim Inds

2784.4 22.40

HCL Technologies

1619.8 -18.50

HDFC Bank

1983 -0.70

HDFC Life Insur.

764.75 5.75

Hero Motocorp

4251.7 33.00

Hind. Unilever

2516.6 -3.00

Hindalco Inds.

666.5 -4.45

ICICI Bank

1423 1.10

IndusInd Bank

867.6 8.75

Infosys

1570.3 -24.60

ITC

419.4 2.60

JSW Steel

1038.9 1.70

Kotak Mah. Bank

2203.8 -16.80

Larsen & Toubro

3495.9 -44.70

M & M

3092.1 18.90

Maruti Suzuki

12514 -60.00

Nestle India

2392.9 -10.60

NTPC

342.1 -0.60

O N G C

244.22 2.46

Power Grid Corpn

298.2 -0.35

Reliance Industr

1483.7 -11.50

SBI Life Insuran

1851.3 16.10

Shriram Finance

669.75 1.50

St Bk of India

808.85 0.20

Sun Pharma.Inds.

1682.6 10.60

Tata Consumer

1071.8 -5.00

Tata Motors

674.5 -7.30

Tata Steel

160.44 0.60

TCS

3222.7 -43.30

Tech Mahindra

1576.7 -25.80

Titan Company

3404.7 43.10

Trent

5314.5 -49.50

UltraTech Cem.

12516 21.00

Wipro

254.25 -4.05

Corporate News - Detailed News Back
Sun Pharmaceutical Industries launches LEQSELVI' (deuruxolitinib) 8 mg tablets in United States
14-Jul-25   16:48 Hrs IST

Sun Pharmaceutical Industries announced LEQSELVI' (deuruxolitinib) 8 mg tablets is now available to healthcare providers and people living with severe alopecia areata in the U.S.

LEQSELVI is indicated for the treatment of adults with severe alopecia areata.

'The launch of LEQSELVI in the U.S. brings an effective, new treatment option for severe alopecia areata to eligible patients and the healthcare providers who treat them,' said Richard Ascroft, CEO, Sun Pharma North America. 'As a company committed to launching new therapeutic options which address the unmet needs of patients, adding LEQSELVI to our dermatology portfolio represents a key milestone for the business and an important advancement for the alopecia areata community.'

Powered by Capital Market - Live News


DJIA 44384.39
-287.26 -0.64%
S&P 500 6279.98
-21.48 -0.34%
HANG SENG 24203.33
63.75 0.26%
NIKKEI 225 39468.95
-100.73 -0.25%
FTSE 100 8998.06
56.94 0.64%
NIFTY 25082.30
-67.55 -0.27%
×
Ask Your Question
close
refresh